Purchase Order 75N92019P00303

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation for immunosequencing services (ImmunoSEQ MMTCRB sequencing) valued at $12,200.00, with award and completion dates of July 12, 2018 and July 12, 2019 respectively.</p> <p>Performance occurs in Seattle, Washington. The order is firm fixed price with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Innomics Inc. for immune repertoire sequencing services valued at $17,140.00, effective September 13, 2017, with completion on September 13, 2018. Work is performed in Cambridge, Massachusetts. The order is firm fixed price with no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute issued a $233,535.34 delivery order to Illumina, Inc. on September 3, 2014, for TruSeq SBS Kit v3–HS (200-cycle) HiSeq2000 sequencing reagents.</p> <p>Place of performance is Bethesda, MD. Ultimate completion date is August 31, 2015. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation valued at $16,800 on September 6, 2017, with an ultimate completion date of September 14, 2017. Place of performance is Seattle, Washington. The order is for firm fixed-price immunosequencing services. No set-aside category applies.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Adaptive Biotechnologies Corporation for $29,900.00 on September 12, 2019, for ImmunoSEQ HSTCRB V4 assay services. Performance of work is located in Bethesda, Maryland, with a completion date of February 28, 2020. The purchase order was issued without a set-aside designation under a pre-solicitation opportunity posted July 24, 2019.</p>

<p>The National Heart Lung and Blood Institute issued a $80,021.76 delivery order to Illumina, Inc. on July 8, 2011, for 12 units of TruSeq SBS Kit v3 – HS (200-cycles) sequencing reagent kits.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of August 31, 2015. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute issued an $82,024.32 delivery order to Illumina, Inc. on August 6, 2020, for Illumina sequencing kits and reagents supporting next-generation sequencing on Illumina instruments at the NHLBI Sequencing Core Facility.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020.</p>

<p>The National Heart Lung and Blood Institute issued a $9,947.04 delivery order to Illumina, Inc. on July 12, 2017, for DNA sequencing kits to be used for genetic analysis of human immunological cells from patient samples collected over several months.</p> <p>Place of performance is San Diego, CA 92122. Ultimate completion date is September 2, 2020. The order is priced on a firm fixed-price basis with no set-aside designation.</p>

The National Heart Lung and Blood Institute issued a $106,101.30 delivery order to Illumina, Inc. on September 2, 2026, for next-generation sequencing kits and reagents to support the NHLBI Sequencing Core Facility. Place of performance is San Diego, California. The order is firm fixed price with an ultimate completion date of September 2, 2026. The delivery order procures Illumina sequencing kits and reagents required to conduct next-generation sequencing on Illumina instruments for supported...

<p>The National Heart Lung and Blood Institute issued a delivery order to Illumina, Inc. on February 28, 2018, for Illumina kits and reagents for sequencing with a ceiling value of $24,407.80.</p> <p>Place of performance is San Diego, CA 92122. The order was issued on a firm fixed-price basis with no set-aside designation and an ultimate completion date of September 2, 2020.</p>